Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine …

A Asatryan, N Meyer, M Scherbakov… - Human Vaccines & …, 2021 - Taylor & Francis
Full article: Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content
diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in …

Randomized controlled trial of the safety and immunogenicity of revaccination with tetanus-diphtheria-acellular pertussis vaccine (Tdap) in adults 10 years after a …

SA Halperin, C Donovan, GS Marshall… - Journal of the …, 2019 - academic.oup.com
… available Tdap products are not labeled for repeat administration in the United States. …
Most important is that this study evaluated only repeat Tdap vaccination after an interval of …

[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …

FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis
and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV). Hum Vaccin 2010;6:554–61. CrossRef…

[HTML][HTML] Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization …

M Sancovski, N Mesaros, Y Feng… - Human vaccines & …, 2019 - Taylor & Francis
Full article: Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine
when administered during pregnancy as part of the maternal immunization program in Brazil…

[HTML][HTML] Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large …

KP Perrett, SA Halperin, T Nolan, AC Martínez… - Vaccine, 2020 - Elsevier
… ); Tdap, reduced-antigen-content diphtheria-tetanus-acellular … that administration of the
reduced-antigen-content Tdap … by the absence of statistical adjustments for multiple testing. …

[HTML][HTML] Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen …

P Pitisuttithum, J Dhitavat, C Sirivichayakul… - …, 2021 - thelancet.com
Background Recombinant pertussis vaccines inducing long-lasting immune responses could
help to control the rise in pertussis. We here report on persisting antibody responses 2 and …

[HTML][HTML] Immunogenicity and antibody persistence of diphteria-tetanus-acellular pertussis vaccination in adolescents and adults: A systematic review of the literature …

R Squeri, C Genovese - Journal of Preventive Medicine and …, 2020 - ncbi.nlm.nih.gov
… to choose a vaccine with multiple Bordetella pertussis components (Tdap3 or Tdap5). …
combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as …

[HTML][HTML] Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial

F Martinón-Torres, SA Halperin, T Nolan, B Tapiéro… - Vaccine, 2021 - Elsevier
… tetanus-reduced-antigen-content diphtheria-three-component acellular pertussis vaccine (…
In addition, because our study was descriptive and no adjustments for multiple comparisons …

Boosting teenagers with acellular pertussis vaccines containing recombinant or chemically inactivated pertussis toxin: a randomized clinical trial

G Blanchard Rohner, O Chatzis… - Clinical Infectious …, 2019 - academic.oup.com
… of efficacy may derive from repeat immunizations with cdPT-… /adults include the administration
of repeat doses of r-aP. … reflect interference of concomitant Td administration. If such, …

[HTML][HTML] Fourteen years of the Pregnancy Registry on maternal immunisation with a reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap) vaccine

A Kuznetsova, MA Ceregido, A Jourquin, L Campora… - Vaccine, 2022 - Elsevier
administration of one dose of the reduced-antigen-content tetanus-diphtheria-acellular pertussis
(… Reports of multiple exposures (ie, multiple administrations of Tdap-containing vaccine) …